Genetron
in drug development services for i a | Genetron
Company
Deck Type
Sector
Industry
Deck date
June 2022
Slide
13 of 29
Related slides by other companies
BenevolentAI
Investor Conference
January 2024
partnership benevolent | BenevolentAI
AbCellera
Investor Conference
January 2024
continued focus on high value programs and strategic partnerships with our differentiated technology position in liquidity we have a long cash runway for focused investment execution completion of engine over the next years we will continue to invest in the final stage of our engine including construction commissioning of our manufacturing facility our portfolio of partnered in we anticipate partnership deals from our cell engager platform our partnership strategy is to select high value not deal volume our portfolio of internal we expect to enter clinical development in in we expect additional first in class development candidates from our ion channel platform | AbCellera
Alkermes
Investor Conference
January 2024
proven drug development capabilities | Alkermes
Falcon's Beyond
Investor Presentation
April 2023
key brand partnerships strategically partnered with leading developers and distributers of brands to further power our monetization engine he falcons epic story media | Falcon's Beyond
Other recent decks by Genetron
See all presentations (5 decks)
Results
August 2021
Results
May 2021
Results
April 2021
IPO
July 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights